Structure

Physi-Chem Properties

Molecular Weight:  786.09
Volume:  696.483
LogP:  1.479
LogD:  1.001
LogS:  -3.538
# Rotatable Bonds:  6
TPSA:  377.42
# H-Bond Aceptor:  22
# H-Bond Donor:  13
# Rings:  6
# Heavy Atoms:  22

MedChem Properties

QED Drug-Likeness Score:  0.057
Synthetic Accessibility Score:  6.145
Fsp3:  0.176
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -7.08
MDCK Permeability:  1.053610958479112e-05
Pgp-inhibitor:  0.429
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.976
20% Bioavailability (F20%):  0.95
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  88.85518646240234%
Volume Distribution (VD):  0.477
Pgp-substrate:  28.61349868774414%

ADMET: Metabolism

CYP1A2-inhibitor:  0.268
CYP1A2-substrate:  0.004
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.02
CYP2C9-inhibitor:  0.465
CYP2C9-substrate:  0.023
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.068
CYP3A4-inhibitor:  0.014
CYP3A4-substrate:  0.001

ADMET: Excretion

Clearance (CL):  7.217
Half-life (T1/2):  0.966

ADMET: Toxicity

hERG Blockers:  0.032
Human Hepatotoxicity (H-HT):  0.193
Drug-inuced Liver Injury (DILI):  0.978
AMES Toxicity:  0.096
Rat Oral Acute Toxicity:  0.0
Maximum Recommended Daily Dose:  0.012
Skin Sensitization:  0.958
Carcinogencity:  0.005
Eye Corrosion:  0.003
Eye Irritation:  0.925
Respiratory Toxicity:  0.004

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC80956

Natural Product ID:  NPC80956
Common Name*:   Mallorepanin
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  QLLMARJXKLXEEY-LXPSXXTQSA-N
Standard InCHI:  InChI=1S/C34H26O22/c35-12-1-8(2-13(36)21(12)41)30(48)54-28-17(40)6-11-20(26(28)46)19-10(5-16(39)23(43)25(19)45)32(50)52-7-18-24(44)29(55-33(11)51)27(47)34(53-18)56-31(49)9-3-14(37)22(42)15(38)4-9/h1-6,18,24,27,29,34-47H,7H2/t18-,24-,27-,29+,34+/m1/s1
SMILES:  c1c(cc(c(c1O)O)O)C(=O)Oc1c(cc2c(-c3c(cc(c(c3O)O)O)C(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)c3cc(c(c(c3)O)O)O)O)OC2=O)O)c1O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2289445
PubChem CID:   11479809
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27007 Cunonia macrophylla Species Cunoniaceae Eukaryota n.a. New Caledonia n.a. PMID[15652581]
NPO27007 Cunonia macrophylla Species Cunoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO27007 Cunonia macrophylla Species Cunoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO27007 Cunonia macrophylla Species Cunoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 100000.0 nM PMID[551705]
NPT20 Organism Candida albicans Candida albicans IZ = 10.0 mm PMID[551705]
NPT1285 Organism Corynebacterium accolens Corynebacterium accolens IZ = 10.0 mm PMID[551705]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 10.0 mm PMID[551705]
NPT1286 Organism Pectobacterium carotovorum Pectobacterium carotovorum IZ = 15.0 mm PMID[551705]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC80956 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9759 High Similarity NPC297574
0.9759 High Similarity NPC472723
0.9649 High Similarity NPC173872
0.9649 High Similarity NPC119094
0.9647 High Similarity NPC111490
0.9647 High Similarity NPC261623
0.9645 High Similarity NPC129533
0.9645 High Similarity NPC123259
0.9588 High Similarity NPC231254
0.9586 High Similarity NPC8940
0.9535 High Similarity NPC269046
0.9535 High Similarity NPC7839
0.9535 High Similarity NPC477083
0.9535 High Similarity NPC477081
0.9535 High Similarity NPC142291
0.9532 High Similarity NPC469650
0.9515 High Similarity NPC470271
0.9515 High Similarity NPC311389
0.948 High Similarity NPC31208
0.948 High Similarity NPC160543
0.948 High Similarity NPC472720
0.948 High Similarity NPC469652
0.948 High Similarity NPC93065
0.948 High Similarity NPC472724
0.948 High Similarity NPC472721
0.9477 High Similarity NPC65489
0.9477 High Similarity NPC469649
0.9477 High Similarity NPC260521
0.9477 High Similarity NPC237202
0.9455 High Similarity NPC175793
0.9422 High Similarity NPC158214
0.9422 High Similarity NPC290289
0.9422 High Similarity NPC240200
0.9422 High Similarity NPC223534
0.9405 High Similarity NPC263119
0.9405 High Similarity NPC473550
0.9405 High Similarity NPC34436
0.9405 High Similarity NPC166674
0.9405 High Similarity NPC46640
0.9405 High Similarity NPC219600
0.9401 High Similarity NPC470272
0.9401 High Similarity NPC181778
0.9398 High Similarity NPC261411
0.9398 High Similarity NPC43918
0.9398 High Similarity NPC473818
0.9398 High Similarity NPC190204
0.9368 High Similarity NPC187632
0.9368 High Similarity NPC201814
0.9357 High Similarity NPC208797
0.9357 High Similarity NPC53680
0.9341 High Similarity NPC149300
0.9318 High Similarity NPC476358
0.9318 High Similarity NPC477082
0.9314 High Similarity NPC264302
0.9314 High Similarity NPC97924
0.9314 High Similarity NPC40078
0.9314 High Similarity NPC471091
0.9294 High Similarity NPC79736
0.9294 High Similarity NPC67629
0.9286 High Similarity NPC47521
0.9281 High Similarity NPC31034
0.9273 High Similarity NPC291957
0.9273 High Similarity NPC14030
0.9244 High Similarity NPC125352
0.924 High Similarity NPC267549
0.9226 High Similarity NPC198125
0.9226 High Similarity NPC95421
0.9217 High Similarity NPC470898
0.9181 High Similarity NPC473713
0.9118 High Similarity NPC65333
0.9118 High Similarity NPC38438
0.9112 High Similarity NPC197708
0.9112 High Similarity NPC658
0.9106 High Similarity NPC189312
0.9106 High Similarity NPC3474
0.9102 High Similarity NPC121290
0.908 High Similarity NPC297503
0.908 High Similarity NPC97119
0.908 High Similarity NPC135831
0.9075 High Similarity NPC471030
0.9064 High Similarity NPC88560
0.9064 High Similarity NPC175230
0.9064 High Similarity NPC172033
0.9059 High Similarity NPC149011
0.9059 High Similarity NPC204937
0.9042 High Similarity NPC285108
0.9042 High Similarity NPC33298
0.9036 High Similarity NPC289346
0.9036 High Similarity NPC24164
0.9034 High Similarity NPC105591
0.9034 High Similarity NPC179947
0.903 High Similarity NPC238419
0.903 High Similarity NPC172419
0.9023 High Similarity NPC170203
0.9017 High Similarity NPC476623
0.9017 High Similarity NPC476619
0.9017 High Similarity NPC476622
0.9017 High Similarity NPC476620
0.9017 High Similarity NPC476621
0.9017 High Similarity NPC476618
0.9006 High Similarity NPC102851
0.9006 High Similarity NPC100251
0.9006 High Similarity NPC174140
0.9006 High Similarity NPC5786
0.9006 High Similarity NPC47140
0.9006 High Similarity NPC67134
0.8983 High Similarity NPC473618
0.8977 High Similarity NPC104910
0.8977 High Similarity NPC474093
0.8976 High Similarity NPC87317
0.8971 High Similarity NPC132111
0.897 High Similarity NPC88803
0.897 High Similarity NPC300845
0.897 High Similarity NPC104983
0.897 High Similarity NPC247629
0.897 High Similarity NPC250436
0.897 High Similarity NPC291948
0.897 High Similarity NPC239019
0.897 High Similarity NPC318432
0.8966 High Similarity NPC472725
0.8966 High Similarity NPC472726
0.896 High Similarity NPC472991
0.896 High Similarity NPC472992
0.8953 High Similarity NPC472993
0.8953 High Similarity NPC98583
0.8953 High Similarity NPC163165
0.8941 High Similarity NPC217781
0.8935 High Similarity NPC162169
0.8935 High Similarity NPC166851
0.8929 High Similarity NPC476372
0.8929 High Similarity NPC90905
0.8929 High Similarity NPC4013
0.8929 High Similarity NPC476371
0.8927 High Similarity NPC269625
0.8927 High Similarity NPC475179
0.8922 High Similarity NPC203020
0.8922 High Similarity NPC24627
0.8922 High Similarity NPC53889
0.8922 High Similarity NPC239966
0.892 High Similarity NPC49690
0.8916 High Similarity NPC114179
0.8916 High Similarity NPC160512
0.8916 High Similarity NPC156818
0.8916 High Similarity NPC68324
0.8916 High Similarity NPC289322
0.8916 High Similarity NPC38779
0.8916 High Similarity NPC1913
0.8914 High Similarity NPC117668
0.8914 High Similarity NPC469371
0.8908 High Similarity NPC472387
0.8908 High Similarity NPC253521
0.8908 High Similarity NPC196127
0.8908 High Similarity NPC293626
0.8908 High Similarity NPC217387
0.8908 High Similarity NPC267680
0.8908 High Similarity NPC258044
0.8908 High Similarity NPC37668
0.8908 High Similarity NPC113836
0.8882 High Similarity NPC142707
0.8882 High Similarity NPC49983
0.8882 High Similarity NPC26536
0.8882 High Similarity NPC317671
0.8876 High Similarity NPC67959
0.8864 High Similarity NPC199172
0.8864 High Similarity NPC470718
0.8864 High Similarity NPC35924
0.8862 High Similarity NPC114791
0.8862 High Similarity NPC37502
0.8862 High Similarity NPC318826
0.8862 High Similarity NPC40702
0.8862 High Similarity NPC210501
0.8862 High Similarity NPC141331
0.8862 High Similarity NPC267627
0.8862 High Similarity NPC104222
0.8862 High Similarity NPC160780
0.8862 High Similarity NPC289811
0.8857 High Similarity NPC198902
0.8857 High Similarity NPC212290
0.8851 High Similarity NPC144097
0.8851 High Similarity NPC61904
0.8844 High Similarity NPC316539
0.8837 High Similarity NPC52598
0.8837 High Similarity NPC476365
0.883 High Similarity NPC116745
0.883 High Similarity NPC249977
0.883 High Similarity NPC45400
0.883 High Similarity NPC298847
0.8824 High Similarity NPC7752
0.8824 High Similarity NPC165720
0.8824 High Similarity NPC142614
0.882 High Similarity NPC97817
0.882 High Similarity NPC72554
0.882 High Similarity NPC30011
0.8814 High Similarity NPC470713
0.8814 High Similarity NPC470720
0.8814 High Similarity NPC470416
0.8814 High Similarity NPC470717
0.8814 High Similarity NPC25946
0.8814 High Similarity NPC460984
0.8814 High Similarity NPC318119

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC80956 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9006 High Similarity NPD7993 Clinical (unspecified phase)
0.897 High Similarity NPD4868 Clinical (unspecified phase)
0.8735 High Similarity NPD1465 Phase 2
0.8671 High Similarity NPD5844 Phase 1
0.8621 High Similarity NPD7074 Phase 3
0.8621 High Similarity NPD7472 Approved
0.8613 High Similarity NPD3818 Discontinued
0.858 High Similarity NPD4338 Clinical (unspecified phase)
0.8563 High Similarity NPD7054 Approved
0.8475 Intermediate Similarity NPD7808 Phase 3
0.8466 Intermediate Similarity NPD6797 Phase 2
0.8427 Intermediate Similarity NPD8313 Approved
0.8427 Intermediate Similarity NPD8312 Approved
0.8418 Intermediate Similarity NPD7251 Discontinued
0.84 Intermediate Similarity NPD7228 Approved
0.8398 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8391 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8391 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8391 Intermediate Similarity NPD6166 Phase 2
0.8363 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8294 Intermediate Similarity NPD8455 Phase 2
0.8218 Intermediate Similarity NPD7199 Phase 2
0.8208 Intermediate Similarity NPD6234 Discontinued
0.8171 Intermediate Similarity NPD6232 Discontinued
0.8135 Intermediate Similarity NPD8151 Discontinued
0.8129 Intermediate Similarity NPD1934 Approved
0.8129 Intermediate Similarity NPD37 Approved
0.8114 Intermediate Similarity NPD6959 Discontinued
0.8108 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD1653 Approved
0.8092 Intermediate Similarity NPD4965 Approved
0.8092 Intermediate Similarity NPD4966 Approved
0.8092 Intermediate Similarity NPD4967 Phase 2
0.8045 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8034 Intermediate Similarity NPD7473 Discontinued
0.8023 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD7240 Approved
0.8011 Intermediate Similarity NPD6559 Discontinued
0.8011 Intermediate Similarity NPD7685 Pre-registration
0.7978 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7977 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD3749 Approved
0.7941 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD3751 Discontinued
0.7874 Intermediate Similarity NPD7819 Suspended
0.7874 Intermediate Similarity NPD2801 Approved
0.7865 Intermediate Similarity NPD3787 Discontinued
0.7829 Intermediate Similarity NPD3817 Phase 2
0.7803 Intermediate Similarity NPD4380 Phase 2
0.7784 Intermediate Similarity NPD7768 Phase 2
0.7784 Intermediate Similarity NPD3882 Suspended
0.7778 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7783 Phase 2
0.774 Intermediate Similarity NPD7075 Discontinued
0.7692 Intermediate Similarity NPD3750 Approved
0.7661 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD1511 Approved
0.7657 Intermediate Similarity NPD7411 Suspended
0.7654 Intermediate Similarity NPD5494 Approved
0.7627 Intermediate Similarity NPD5402 Approved
0.7627 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD7680 Approved
0.7602 Intermediate Similarity NPD7435 Discontinued
0.7577 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD1512 Approved
0.7571 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD6190 Approved
0.7543 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD6780 Approved
0.7538 Intermediate Similarity NPD6776 Approved
0.7538 Intermediate Similarity NPD6781 Approved
0.7538 Intermediate Similarity NPD6782 Approved
0.7538 Intermediate Similarity NPD6777 Approved
0.7538 Intermediate Similarity NPD6779 Approved
0.7538 Intermediate Similarity NPD6778 Approved
0.753 Intermediate Similarity NPD230 Phase 1
0.7515 Intermediate Similarity NPD7266 Discontinued
0.7514 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD6801 Discontinued
0.7485 Intermediate Similarity NPD4628 Phase 3
0.7475 Intermediate Similarity NPD7871 Phase 2
0.7475 Intermediate Similarity NPD7870 Phase 2
0.7471 Intermediate Similarity NPD1549 Phase 2
0.747 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD1613 Approved
0.7463 Intermediate Similarity NPD7874 Approved
0.7463 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD5403 Approved
0.7424 Intermediate Similarity NPD7698 Approved
0.7424 Intermediate Similarity NPD7697 Approved
0.7424 Intermediate Similarity NPD7696 Phase 3
0.7418 Intermediate Similarity NPD8127 Discontinued
0.7412 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD3748 Approved
0.7368 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD7701 Phase 2
0.7356 Intermediate Similarity NPD6799 Approved
0.7345 Intermediate Similarity NPD7458 Discontinued
0.7326 Intermediate Similarity NPD6674 Discontinued
0.7326 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD2533 Approved
0.7314 Intermediate Similarity NPD2534 Approved
0.7314 Intermediate Similarity NPD5401 Approved
0.7314 Intermediate Similarity NPD2532 Approved
0.7314 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD6599 Discontinued
0.73 Intermediate Similarity NPD8319 Approved
0.73 Intermediate Similarity NPD8320 Phase 1
0.7286 Intermediate Similarity NPD6823 Phase 2
0.7282 Intermediate Similarity NPD6534 Approved
0.7282 Intermediate Similarity NPD6535 Approved
0.7273 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD7699 Phase 2
0.7259 Intermediate Similarity NPD7700 Phase 2
0.7257 Intermediate Similarity NPD7390 Discontinued
0.7255 Intermediate Similarity NPD7801 Approved
0.7247 Intermediate Similarity NPD3226 Approved
0.7243 Intermediate Similarity NPD3926 Phase 2
0.724 Intermediate Similarity NPD8150 Discontinued
0.7229 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD919 Approved
0.7193 Intermediate Similarity NPD1510 Phase 2
0.7192 Intermediate Similarity NPD7585 Approved
0.719 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7229 Phase 3
0.7186 Intermediate Similarity NPD3027 Phase 3
0.7175 Intermediate Similarity NPD6273 Approved
0.7151 Intermediate Similarity NPD2796 Approved
0.715 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD7583 Approved
0.7143 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD7177 Discontinued
0.712 Intermediate Similarity NPD7549 Discontinued
0.7118 Intermediate Similarity NPD1933 Approved
0.7118 Intermediate Similarity NPD447 Suspended
0.7086 Intermediate Similarity NPD7003 Approved
0.7086 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD4287 Approved
0.7059 Intermediate Similarity NPD943 Approved
0.7059 Intermediate Similarity NPD5242 Approved
0.7056 Intermediate Similarity NPD6213 Phase 3
0.7056 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD6212 Phase 3
0.7052 Intermediate Similarity NPD5406 Approved
0.7052 Intermediate Similarity NPD5404 Approved
0.7052 Intermediate Similarity NPD5408 Approved
0.7052 Intermediate Similarity NPD1551 Phase 2
0.7052 Intermediate Similarity NPD5405 Approved
0.7049 Intermediate Similarity NPD5353 Approved
0.7042 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD3764 Approved
0.7035 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD4908 Phase 1
0.7015 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.6989 Remote Similarity NPD8166 Discontinued
0.6979 Remote Similarity NPD7038 Approved
0.6979 Remote Similarity NPD7039 Approved
0.6976 Remote Similarity NPD7584 Approved
0.697 Remote Similarity NPD9269 Phase 2
0.6959 Remote Similarity NPD1240 Approved
0.6957 Remote Similarity NPD4288 Approved
0.6954 Remote Similarity NPD6099 Approved
0.6954 Remote Similarity NPD6100 Approved
0.6954 Remote Similarity NPD2935 Discontinued
0.6952 Remote Similarity NPD1247 Approved
0.6944 Remote Similarity NPD920 Approved
0.6941 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6798 Discontinued
0.6939 Remote Similarity NPD6841 Approved
0.6939 Remote Similarity NPD6843 Phase 3
0.6939 Remote Similarity NPD6842 Approved
0.6936 Remote Similarity NPD7097 Phase 1
0.6927 Remote Similarity NPD642 Clinical (unspecified phase)
0.6915 Remote Similarity NPD5710 Approved
0.6915 Remote Similarity NPD5711 Approved
0.6914 Remote Similarity NPD2346 Discontinued
0.6905 Remote Similarity NPD7930 Approved
0.69 Remote Similarity NPD7667 Clinical (unspecified phase)
0.6897 Remote Similarity NPD651 Clinical (unspecified phase)
0.6879 Remote Similarity NPD1607 Approved
0.6864 Remote Similarity NPD9494 Approved
0.6863 Remote Similarity NPD5006 Approved
0.6863 Remote Similarity NPD5005 Approved
0.6839 Remote Similarity NPD5953 Discontinued
0.6836 Remote Similarity NPD1243 Approved
0.6836 Remote Similarity NPD1652 Phase 2
0.6821 Remote Similarity NPD5124 Phase 1
0.6821 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6816 Remote Similarity NPD643 Clinical (unspecified phase)
0.6807 Remote Similarity NPD1091 Approved
0.6802 Remote Similarity NPD6233 Phase 2
0.68 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6793 Remote Similarity NPD6386 Approved
0.6793 Remote Similarity NPD7615 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data